Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 43 studies | 46% ± 19% | |
connective tissue cell | 19 studies | 42% ± 17% | |
endothelial cell of lymphatic vessel | 15 studies | 35% ± 15% | |
mesothelial cell | 14 studies | 60% ± 19% | |
smooth muscle cell | 14 studies | 26% ± 8% | |
pericyte | 13 studies | 28% ± 7% | |
ciliated cell | 12 studies | 39% ± 15% | |
myofibroblast cell | 9 studies | 30% ± 7% | |
adipocyte | 8 studies | 36% ± 19% | |
epithelial cell | 5 studies | 26% ± 12% | |
astrocyte | 5 studies | 22% ± 6% | |
adventitial cell | 5 studies | 72% ± 14% | |
respiratory goblet cell | 4 studies | 36% ± 1% | |
secretory cell | 4 studies | 31% ± 11% | |
abnormal cell | 3 studies | 26% ± 2% | |
basal cell | 3 studies | 30% ± 12% | |
club cell | 3 studies | 27% ± 16% | |
Mueller cell | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 92% | 25249.52 | 423 / 459 | 93% | 62.89 | 1036 / 1118 |
thymus | 96% | 17217.40 | 624 / 653 | 79% | 45.68 | 480 / 605 |
uterus | 99% | 31234.52 | 168 / 170 | 67% | 43.13 | 309 / 459 |
lung | 76% | 13122.96 | 440 / 578 | 85% | 39.06 | 979 / 1155 |
skin | 73% | 46666.42 | 1323 / 1809 | 67% | 26.30 | 318 / 472 |
ovary | 81% | 8970.69 | 145 / 180 | 60% | 20.96 | 257 / 430 |
prostate | 74% | 10434.22 | 182 / 245 | 64% | 15.26 | 321 / 502 |
esophagus | 71% | 13811.52 | 1022 / 1445 | 56% | 20.61 | 102 / 183 |
bladder | 67% | 13024.48 | 14 / 21 | 48% | 17.40 | 243 / 504 |
pancreas | 17% | 1083.26 | 57 / 328 | 89% | 79.29 | 158 / 178 |
intestine | 61% | 8444.87 | 586 / 966 | 40% | 17.98 | 209 / 527 |
adipose | 99% | 33992.78 | 1186 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 17794.37 | 1270 / 1335 | 0% | 0 | 0 / 0 |
stomach | 39% | 6217.07 | 141 / 359 | 56% | 26.20 | 159 / 286 |
brain | 1% | 36.97 | 20 / 2642 | 94% | 52.57 | 663 / 705 |
heart | 83% | 18422.09 | 712 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 23.51 | 33 / 45 |
kidney | 18% | 1332.61 | 16 / 89 | 41% | 14.18 | 365 / 901 |
spleen | 51% | 3421.73 | 123 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 16% | 885.84 | 42 / 258 | 29% | 9.46 | 66 / 230 |
lymph node | 0% | 0 | 0 / 0 | 41% | 9.60 | 12 / 29 |
liver | 0% | 66.37 | 1 / 226 | 25% | 6.63 | 101 / 406 |
eye | 0% | 0 | 0 / 0 | 8% | 1.59 | 6 / 80 |
muscle | 5% | 359.91 | 44 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 40.17 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
GO_0009617 | Biological process | response to bacterium |
GO_0005604 | Cellular component | basement membrane |
GO_0005614 | Cellular component | interstitial matrix |
GO_0005576 | Cellular component | extracellular region |
GO_0008201 | Molecular function | heparin binding |
GO_0001968 | Molecular function | fibronectin binding |
Gene name | CCDC80 |
Protein name | Coiled-coil domain-containing protein 80 Coiled-coil domain-containing protein 80 (Down-regulated by oncogenes protein 1) (Up-regulated in BRS-3 deficient mouse homolog) |
Synonyms | URB HBE245 DRO1 |
Description | FUNCTION: Promotes cell adhesion and matrix assembly. . |
Accessions | ENST00000206423.8 [Q76M96-1] Q76M96 ENST00000479368.1 H7C5K4 C9J8I6 ENST00000461431.1 ENST00000439685.6 [Q76M96-1] |